Now Enrolling New Participants
Menstrual migraines start before or during a woman’s period and can happen every month. Common symptoms include a dull throbbing or severe pulsing headache, sensitivity to light, nausea, fatigue, dizziness and more.
Join a clinical research study of an investigational medication for migraine prevention. Women aged 18 and above, experiencing migraines just prior and/or during their period may be eligible.
Qualified participants may receive:
- Study-related care and study medication at no cost.
- Compensation for each study visit completed.
- The chance to advance migraine research.
Participants who qualify meet the following criteria:
- Women aged 18 and above.
- Menstrual cycle is between 21 to 35 days.
- One-year history of migraine with or without aura with onset before age 50.
- Has less than 15 headache days per month.
- Migraines occur just prior and/or during period.
Additional requirements to qualify for this study will apply. A member of the study team will discuss these with you.
What is a clinical research study?
A clinical research study tests the safety and effectiveness of an investigational medication in human volunteers. Every new medication must be tested in this way before it can be used by the public. People who participate in these studies play a crucial role in helping doctors and researchers learn more about how to treat illnesses in the future.